Clinical trial
Can we Antagonize Mivacurium With Neostigmine
NCT03019835 is registered in ClinicalTrials.gov with Université Libre de Bruxelles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can we Antagonize Mivacurium With Neostigmine
- Lead sponsor
- Université Libre de Bruxelles
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- April 22, 2017
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mivacurium, neostigmine, residual paralysis